Knowledge

Gigantism

Source đź“ť

462: 64: 486: 443: 245:
As a result of the excessive amounts of growth hormone, children achieve heights that are well above normal ranges. The specific age of onset for gigantism varies between patients and gender, but the common age that excessive growth symptoms start to appear has been found to be around 13 years. Other
284:
More broadly, GH and IGF have both been identified to be involved in most stages of growth: embryonic, prenatal, and postnatal. Moreover, the receptor gene for IGF has been shown to be particularly influential throughout various stages of development, especially prenatally. This is the same for GH
327:
have been associated with gigantism. Pediatric gigantism patients have shown to have duplications of genes on a specific chromosome, Xq26. Typically, these patients also experienced an onset of typical gigantism symptoms before reaching the age of 5. This indicates a possible linkage between
307:
Insulin-like growth factor-1 (IGF-1) is an excellent test for evaluation of GH hyper-secretion. It does not undergo diurnal variation and will thus be consistently elevated in GH hyper-secretion and therefore patients with gigantism. A single normal IGF-1 value will reliably exclude GH
998:
Zimmerman, D; Young, W F; Ebersold, M J; Scheithauer, B W; Kovacs, K; Horvath, E; Whitaker, M D; Eberhardt, N L; Downs, T R (1 January 1993). "Congenital gigantism due to growth hormone-releasing hormone excess and pituitary hyperplasia with adenomatous transformation".
1443:
Vierimaa, Outi; Georgitsi, Marianthi; Lehtonen, Rainer; Vahteristo, Pia; Kokko, Antti; Raitila, Anniina; Tuppurainen, Karoliina; Ebeling, Tapani M. L.; Salmela, Pasi I. (26 May 2006). "Pituitary Adenoma Predisposition Caused by Germline Mutations in the AIP Gene".
304:. However, a random blood sample showing markedly elevated GH is adequate for diagnosis of GH hyper-secretion. Additionally, a high-normal GH level that fails to suppress with administration of glucose is also sufficient for a diagnosis of GH hyper-secretion. 113:, weakness and severe or recurrent headaches, strokes, vomiting or nausea, high fevers, daytime sleepiness or narcolepsy, dry mouth, frequent diarrheas, stomachaches, ear pains, memory loss, back pains, excessive muscle cramps, chest pains 357:
Two specific mutations in the AIP gene have been identified as possible causes of pituitary adenomas. These mutations also have the ability to cause adenoma growth to occur early in life. This is typical in gigantism.
1773: 1754: 1735: 406:
After treatment with pegvisomant, high growth rates, a feature characteristic of gigantism, can be significantly decreased. Pegvisomant has been seen to be a powerful alternative to other treatments such as
671: 506:
above mean for persons of the same sex, age, and ethnic ancestry. The term is seldom applied to those who are simply "tall" or "above average" whose heights appear to be the result of normal
281:(IGF-I) are two substances that have been identified as influencing growth plate formation and bone growth and, therefore, gigantism. Their specific mechanisms are still not well understood. 787:
Rostomyan, Liliya; Daly, Adrian F.; Petrossians, Patrick; Nachev, Emil; Lila, Anurag R.; Lecoq, Anne-Lise; Lecumberri, Beatriz; Trivellin, Giampaolo; Salvatori, Roberto (October 2015).
1095:. In De Groot, Leslie J.; Chrousos, George; Dungan, Kathleen; Feingold, Kenneth R.; Grossman, Ashley; Hershman, Jerome M.; Koch, Christian; Korbonits, Márta; McLachlan, Robert (eds.). 320:
cause for gigantism has proven to be difficult. Gigantism is the primary example of growth hormone hyper-secretion disorders, a group of illnesses that are not yet deeply understood.
1334:
Trivellin, Giampaolo; Daly, Adrian F.; Faucz, Fabio R.; Yuan, Bo; Rostomyan, Liliya; Larco, Darwin O.; Schernthaner-Reiter, Marie Helene; Szarek, Eva; Leal, LetĂ­cia F. (2014).
376:
Although various gene mutations have been associated with gigantism, over 50 percent of cases cannot be linked to genetic causes, showing the complex nature of the disorder.
1388:"Familial Isolated Pituitary Adenomas (FIPA) and the Pituitary Adenoma Predisposition due to Mutations in the Aryl Hydrocarbon Receptor Interacting Protein (AIP) Gene" 384:
Many treatments for gigantism receive criticism and are not accepted as ideal. Various treatments involving surgery and drugs have been used to treat gigantism.
753: 1878:
Gigantism information from U.S. National Library of Medicine, U.S. Department of Health and Human Services & the National Institutes of Health
339:) gene are common in gigantism patients. They have been found to be present in about 29 percent of patients with gigantism. AIP is labeled as a 292:) of IGF-I, but each has its independent role in hormonal pathways. Yet both seem to ultimately come together to have a joint effect on growth. 514:
of the brain. It causes growth of the hands, face, and feet. In some cases the condition can be passed on genetically through a mutated gene.
1843: 544:
great). In the past, while many of them were social outcasts because of their height, some (usually unintentionally) found employment in
611: 1909: 361:
Additionally, a large variety of other known genetic disorders have been found to influence the development of gigantism such as
1703: 418:
Finding the optimal level of pegvisomant is important so normal body growth is not negatively affected. In order to do this,
855:
Rostomyan, Liliya; Potorac, Iulia; Beckers, Pablo; Daly, Adrian F.; Beckers, Albert (2017). "AIP mutations and gigantism".
676: 239: 1545:
Goldenberg, Naila; Racine, Michael S.; Thomas, Pamela; Degnan, Bernard; Chandler, William; Barkan, Ariel (1 August 2008).
362: 1651: 1503:
Rostomyan, Liliya; Daly, Adrian F.; Beckers, Albert (2015). "Pituitary gigantism: Causes and clinical characteristics".
206:
which usually occurs at some point soon after puberty. This increase is most often due to abnormal tumor growths on the
1279:
Sanders, Esmond J.; Harvey, Steve (2004). "Growth hormone as an early embryonic growth and differentiation factor".
789:"Clinical and genetic characterization of pituitary gigantism: an international collaborative study in 208 patients" 354:, can have deleterious effects by inducing the development of pituitary adenomas which in turn can cause gigantism. 230:(GH). The excess of growth hormone that brings about gigantism is virtually always caused by pituitary growths ( 1999: 545: 1883:
Epidemiology of acromegaly from Pubmed.gov US National Library of Medicine & National Institutes of Health
502:
The term is typically applied to those whose height is not just in the upper 1% of the population but several
1902: 403:
as a result of pegvisomant administration can be incredibly beneficial for the pediatric gigantism patients.
289: 399:
which has received attention for being a possible treatment route for gigantism. Reduction of the levels of
400: 366: 278: 1887: 1994: 1946: 1677:
In a Giant's Story, a New Chapter Writ by His DNA – By Gina Kolata. The New York Times, January 5, 2011
555:
Many of those who have been identified with gigantism have had multiple health problems involving the
1979: 476: 1238:
Lupu, Floria; Terwilliger, Joseph D.; Lee, Kaechoong; Segre, Gino V.; Efstratiadis, Argiris (2001).
300:
Evaluation of growth hormone hypersecretion cannot be excluded with a single normal GH level due to
1989: 1895: 1788: 17: 1850: 1324:
De Mais, Daniel. ASCP Quick Compendium of Clinical Pathology, 2nd Ed. ASCP Press, Chicago, 2009.
202:
It is a rare disorder resulting from increased levels of growth hormone before the fusion of the
104: 2004: 621: 1877: 1828: 1984: 1744: 1693: 340: 1748: 1453: 754:"Gigantism and Acromegaly – Hormonal and Metabolic Disorders – MSD Manual Consumer Version" 606: 1547:"Treatment of Pituitary Gigantism with the Growth Hormone Receptor Antagonist Pegvisomant" 461: 285:
receptor genes which have been known to drive overall growth throughout various pathways.
8: 1936: 1777: 1676: 740:"Gigantism and Acromegaly: Practice Essentials, Background, Pathophysiology and Etiology" 646: 396: 1604:"Pegvisomant therapy in pituitary gigantism: successful treatment in a 12-year-old girl" 1457: 739: 1579: 1546: 1485: 1420: 1387: 1360: 1335: 1304: 1212: 1179: 1152: 1119: 926: 891: 821: 788: 596: 586: 563:, as the strain of maintaining a large, heavy body places abnormal demands on both the 556: 503: 235: 91: 31: 1782: 467: 411:
analogues, a common treatment method for acromegaly, if drug treatment is paired with
1799: 1699: 1633: 1625: 1584: 1566: 1520: 1477: 1469: 1425: 1407: 1365: 1296: 1261: 1217: 1199: 1157: 1139: 1100: 1073: 1065: 1024: 1016: 980: 972: 931: 913: 872: 826: 808: 511: 412: 344: 301: 215: 79: 1489: 1308: 1240:"Roles of growth hormone and insulin-like growth factor 1 in mouse postnatal growth" 1919: 1615: 1574: 1558: 1512: 1461: 1415: 1399: 1355: 1347: 1288: 1251: 1207: 1191: 1147: 1131: 1055: 1008: 962: 921: 903: 864: 816: 800: 616: 329: 203: 35: 1386:
Beckers, Albert; Aaltonen, Lauri A.; Daly, Adrian F.; Karhu, Auli (1 April 2013).
714: 335:
Additionally, DNA mutations in the aryl hydrocarbon receptor interacting protein (
191:, is a condition characterized by excessive growth and height significantly above 1793: 631: 626: 560: 207: 136: 125: 110: 1092: 422:
of the medication can be used as a way to find the proper administration level.
1941: 1882: 1804: 1516: 868: 651: 549: 448: 370: 351: 274: 227: 196: 192: 168: 1872: 1767: 1763: 1655: 1292: 1012: 1973: 1629: 1570: 1473: 1411: 1203: 1143: 1135: 1069: 1020: 976: 917: 812: 530: 485: 238:. They can also cause overproduction of GH's hypothalamic precursor known as 84: 71: 1602:
Rix, M.; Laurberg, P.; Hoejberg, A. S.; Brock-Jacobsen, B. (1 August 2005).
1465: 1336:"Gigantism and Acromegaly Due to Xq26 Microduplications and GPR101 Mutation" 1060: 1043: 180: 1917: 1637: 1588: 1524: 1481: 1429: 1369: 1300: 1265: 1256: 1239: 1221: 1161: 1104: 1077: 984: 935: 908: 876: 830: 408: 247: 1351: 1028: 1823: 1562: 1403: 392: 263: 156: 121: 63: 1620: 1603: 1195: 967: 950: 804: 581: 517:
Other names somewhat obsolete for this pathology are hypersoma (Greek:
426: 373:, familial isolated pituitary adenoma, X-linked acrogigantism (X-LAG). 336: 259: 251: 211: 152: 148: 143: 1727: 689: 1951: 636: 492: 419: 255: 1931: 1442: 641: 591: 507: 471: 324: 317: 97: 1873:
Gigantism Clinical Trials from U.S. National Institutes of Health
1601: 997: 601: 452: 442: 258:
of growth hormone. Characteristics more similar to those seen in
231: 1758: 1739: 786: 568: 1544: 195:. In humans, this condition is caused by over-production of 854: 564: 1385: 1180:"Insulin-like growth factor 1 (IGF-1): a growth hormone" 1042:
Eugster, Erica A.; Pescovitz, Ora H. (1 December 1999).
1237: 1551:
The Journal of Clinical Endocrinology & Metabolism
1333: 1048:
The Journal of Clinical Endocrinology & Metabolism
1001:
The Journal of Clinical Endocrinology & Metabolism
218:
enlargement specifically in the extremities and face.
1844:"Brief overview of overgrowth syndromes in childhood" 1717: 1502: 949:
Capatina, Cristina; Wass, John A. H. (August 2015).
890:
Chanson, Philippe; Salenave, Sylvie (25 June 2008).
214:, the adult form of the disorder, characterized by 1124:Annals of Pediatric Endocrinology & Metabolism 1971: 1041: 510:and nutrition. Gigantism is usually caused by a 262:may occur in patients that are closer in age to 96:Abnormal growth in height or size, weakness and 889: 1903: 1278: 1090: 715:"Gigantism: MedlinePlus Medical Encyclopedia" 951:"60 YEARS OF NEUROENDOCRINOLOGY: Acromegaly" 948: 266:since they are nearing growth plate fusion. 226:Gigantism is characterized by an excess of 1910: 1896: 1093:"Disorders of Growth Hormone in Childhood" 690:"Gigantism | UCLA Pituitary Tumor Program" 1691: 1619: 1578: 1419: 1359: 1255: 1211: 1151: 1099:. South Dartmouth (MA): MDText.com, Inc. 1059: 966: 925: 907: 820: 363:multiple endocrine neoplasia type 1 and 4 429:for additional treatment possibilities. 210:. Gigantism should not be confused with 74:stood 8 ft 11 in (2.72 m) 1120:"Pubertal growth and epiphyseal fusion" 14: 1972: 1091:Murray, P. G.; Clayton, P. E. (2000). 1891: 1540: 1538: 1536: 1534: 1381: 1379: 1320: 1318: 1233: 1231: 1177: 1173: 1171: 295: 1117: 850: 848: 846: 844: 842: 840: 782: 780: 778: 776: 774: 612:Hypothalamic–pituitary–somatic axis 24: 1918:Growth and height disorder due to 1531: 1376: 1315: 1272: 1228: 1168: 387: 25: 2016: 1713: 1608:European Journal of Endocrinology 896:Orphanet Journal of Rare Diseases 837: 771: 269: 1695:4QSamuela and the Text of Samuel 484: 460: 441: 240:growth hormone releasing hormone 62: 1685: 1670: 1644: 1595: 1496: 1436: 1340:New England Journal of Medicine 1327: 1111: 1084: 1035: 991: 525:body) and somatomegaly (Greek; 288:Growth hormone is a precursor ( 135:Surgically remove the enlarged 1654:. Question.com. Archived from 942: 883: 746: 732: 707: 682: 665: 432: 246:health complications, such as 13: 1: 1118:Shim, Kye Shik (March 2015). 658: 234:). These adenomas are on the 955:The Journal of Endocrinology 677:Dorland's Medical Dictionary 512:tumor on the pituitary gland 379: 279:insulin-like growth factor-I 7: 758:MSD Manual Consumer Version 574: 350:Mutations in AIP, found by 311: 10: 2021: 1517:10.1016/j.ando.2015.10.002 869:10.1016/j.ando.2017.04.012 29: 1927: 1814: 1721: 1692:Driesbach, Jason (2016). 1293:10.1007/s00429-004-0422-1 1178:Laron, Z (October 2001). 1013:10.1210/jcem.76.1.8421089 172: 142: 131: 117: 103: 90: 78: 70: 61: 53: 48: 1505:Annales d'Endocrinologie 1136:10.6065/apem.2015.20.1.8 857:Annales d'Endocrinologie 793:Endocrine-Related Cancer 367:McCune–Albright syndrome 236:anterior pituitary gland 221: 30:Not to be confused with 1466:10.1126/science.1126100 1061:10.1210/jcem.84.12.6222 521:over the normal level; 1281:Anatomy and Embryology 1257:10.1006/dbio.2000.9975 909:10.1186/1750-1172-3-17 622:List of tallest people 2000:People with gigantism 1352:10.1056/nejmoa1408028 1244:Developmental Biology 341:tumor suppressor gene 27:Human growth disorder 1563:10.1210/jc.2007-2283 1404:10.1210/er.2012-1013 607:Homo heidelbergensis 183:", plural γίγαντες, 109:Excessive sweating, 1937:Primordial dwarfism 1621:10.1530/eje.1.01956 1458:2006Sci...312.1228V 1452:(5777): 1228–1230. 1196:10.1136/mp.54.5.311 1184:Molecular Pathology 968:10.1530/JOE-15-0109 805:10.1530/ERC-15-0320 647:Overgrowth syndrome 546:Friedrich Wilhelm I 504:standard deviations 397:pharmaceutical drug 332:and the gigantism. 316:Finding a specific 1995:Neuroendocrinology 1815:External resources 694:pituitary.ucla.edu 597:Giant of Castelnau 587:Deep-sea gigantism 477:The Princess Bride 347:disposition gene. 296:Diagnostic testing 32:Deep-sea gigantism 1967: 1966: 1838: 1837: 1705:978-90-04-32420-6 1392:Endocrine Reviews 1346:(25): 2363–2374. 1054:(12): 4379–4384. 742:. 7 January 2017. 345:pituitary adenoma 330:gene duplications 302:diurnal variation 187:), also known as 162: 161: 43:Medical condition 16:(Redirected from 2012: 1980:Growth disorders 1912: 1905: 1898: 1889: 1888: 1869: 1865: 1863: 1861: 1855: 1849:. Archived from 1848: 1719: 1718: 1709: 1679: 1674: 1668: 1667: 1665: 1663: 1658:on 13 March 2012 1648: 1642: 1641: 1623: 1599: 1593: 1592: 1582: 1557:(8): 2953–2956. 1542: 1529: 1528: 1500: 1494: 1493: 1440: 1434: 1433: 1423: 1383: 1374: 1373: 1363: 1331: 1325: 1322: 1313: 1312: 1276: 1270: 1269: 1259: 1235: 1226: 1225: 1215: 1175: 1166: 1165: 1155: 1115: 1109: 1108: 1088: 1082: 1081: 1063: 1039: 1033: 1032: 995: 989: 988: 970: 946: 940: 939: 929: 911: 887: 881: 880: 852: 835: 834: 824: 784: 769: 768: 766: 764: 750: 744: 743: 736: 730: 729: 727: 725: 711: 705: 704: 702: 700: 686: 680: 669: 617:Island gigantism 495:with her parents 488: 464: 445: 308:hypersecretion. 174: 66: 46: 45: 36:Island gigantism 21: 2020: 2019: 2015: 2014: 2013: 2011: 2010: 2009: 1990:Growth hormones 1970: 1969: 1968: 1963: 1923: 1916: 1867: 1859: 1857: 1853: 1846: 1842: 1839: 1834: 1833: 1810: 1809: 1730: 1716: 1706: 1688: 1683: 1682: 1675: 1671: 1661: 1659: 1650: 1649: 1645: 1600: 1596: 1543: 1532: 1501: 1497: 1441: 1437: 1384: 1377: 1332: 1328: 1323: 1316: 1277: 1273: 1236: 1229: 1176: 1169: 1116: 1112: 1089: 1085: 1040: 1036: 996: 992: 961:(2): T141–160. 947: 943: 888: 884: 853: 838: 785: 772: 762: 760: 752: 751: 747: 738: 737: 733: 723: 721: 719:medlineplus.gov 713: 712: 708: 698: 696: 688: 687: 683: 670: 666: 661: 656: 632:Marfan syndrome 627:Local gigantism 577: 561:skeletal system 500: 499: 498: 497: 496: 489: 481: 480: 468:AndrĂ© the Giant 465: 457: 456: 451:(1704–1749), a 446: 435: 390: 388:Pharmaceuticals 382: 314: 298: 272: 256:hyper-secretion 250:, may occur in 224: 208:pituitary gland 137:pituitary gland 126:pituitary gland 111:delayed puberty 44: 39: 28: 23: 22: 15: 12: 11: 5: 2018: 2008: 2007: 2002: 1997: 1992: 1987: 1982: 1965: 1964: 1962: 1961: 1956: 1955: 1954: 1949: 1944: 1942:Laron syndrome 1939: 1928: 1925: 1924: 1915: 1914: 1907: 1900: 1892: 1886: 1885: 1880: 1875: 1870: 1868:(2.95 MB) 1856:on 22 May 2004 1836: 1835: 1832: 1831: 1819: 1818: 1816: 1812: 1811: 1808: 1807: 1796: 1785: 1770: 1751: 1731: 1726: 1725: 1723: 1722:Classification 1715: 1714:External links 1712: 1711: 1710: 1704: 1687: 1684: 1681: 1680: 1669: 1643: 1614:(2): 195–201. 1594: 1530: 1511:(6): 643–649. 1495: 1435: 1398:(2): 239–277. 1375: 1326: 1314: 1271: 1250:(1): 141–162. 1227: 1190:(5): 311–316. 1167: 1110: 1083: 1034: 1007:(1): 216–222. 990: 941: 882: 863:(2): 123–130. 836: 799:(5): 745–757. 770: 745: 731: 706: 681: 663: 662: 660: 657: 655: 654: 652:Sotos syndrome 649: 644: 639: 634: 629: 624: 619: 614: 609: 604: 599: 594: 589: 584: 578: 576: 573: 550:Potsdam Giants 490: 483: 482: 466: 459: 458: 449:Daniel Cajanus 447: 440: 439: 438: 437: 436: 434: 431: 389: 386: 381: 378: 371:Carney complex 313: 310: 297: 294: 275:Growth hormone 271: 270:Hormonal cause 268: 254:patients with 228:growth hormone 223: 220: 199:in childhood. 197:growth hormone 160: 159: 146: 140: 139: 133: 129: 128: 119: 115: 114: 107: 101: 100: 94: 88: 87: 82: 76: 75: 68: 67: 59: 58: 55: 51: 50: 42: 26: 9: 6: 4: 3: 2: 2017: 2006: 2005:Rare diseases 2003: 2001: 1998: 1996: 1993: 1991: 1988: 1986: 1983: 1981: 1978: 1977: 1975: 1960: 1957: 1953: 1950: 1948: 1945: 1943: 1940: 1938: 1935: 1934: 1933: 1930: 1929: 1926: 1921: 1913: 1908: 1906: 1901: 1899: 1894: 1893: 1890: 1884: 1881: 1879: 1876: 1874: 1871: 1852: 1845: 1841: 1840: 1830: 1826: 1825: 1821: 1820: 1817: 1813: 1806: 1802: 1801: 1797: 1795: 1791: 1790: 1786: 1784: 1780: 1779: 1775: 1771: 1769: 1765: 1761: 1760: 1756: 1752: 1750: 1746: 1742: 1741: 1737: 1733: 1732: 1729: 1724: 1720: 1707: 1701: 1697: 1696: 1690: 1689: 1678: 1673: 1657: 1653: 1647: 1639: 1635: 1631: 1627: 1622: 1617: 1613: 1609: 1605: 1598: 1590: 1586: 1581: 1576: 1572: 1568: 1564: 1560: 1556: 1552: 1548: 1541: 1539: 1537: 1535: 1526: 1522: 1518: 1514: 1510: 1506: 1499: 1491: 1487: 1483: 1479: 1475: 1471: 1467: 1463: 1459: 1455: 1451: 1447: 1439: 1431: 1427: 1422: 1417: 1413: 1409: 1405: 1401: 1397: 1393: 1389: 1382: 1380: 1371: 1367: 1362: 1357: 1353: 1349: 1345: 1341: 1337: 1330: 1321: 1319: 1310: 1306: 1302: 1298: 1294: 1290: 1286: 1282: 1275: 1267: 1263: 1258: 1253: 1249: 1245: 1241: 1234: 1232: 1223: 1219: 1214: 1209: 1205: 1201: 1197: 1193: 1189: 1185: 1181: 1174: 1172: 1163: 1159: 1154: 1149: 1145: 1141: 1137: 1133: 1129: 1125: 1121: 1114: 1106: 1102: 1098: 1094: 1087: 1079: 1075: 1071: 1067: 1062: 1057: 1053: 1049: 1045: 1038: 1030: 1026: 1022: 1018: 1014: 1010: 1006: 1002: 994: 986: 982: 978: 974: 969: 964: 960: 956: 952: 945: 937: 933: 928: 923: 919: 915: 910: 905: 901: 897: 893: 886: 878: 874: 870: 866: 862: 858: 851: 849: 847: 845: 843: 841: 832: 828: 823: 818: 814: 810: 806: 802: 798: 794: 790: 783: 781: 779: 777: 775: 759: 755: 749: 741: 735: 720: 716: 710: 695: 691: 685: 679: 678: 673: 668: 664: 653: 650: 648: 645: 643: 640: 638: 635: 633: 630: 628: 625: 623: 620: 618: 615: 613: 610: 608: 605: 603: 600: 598: 595: 593: 590: 588: 585: 583: 580: 579: 572: 570: 566: 562: 558: 553: 551: 547: 543: 539: 536:of the body; 535: 532: 528: 524: 520: 515: 513: 509: 505: 494: 487: 479: 478: 474:and actor in 473: 469: 463: 454: 450: 444: 430: 428: 423: 421: 416: 414: 410: 404: 402: 398: 394: 385: 377: 374: 372: 368: 364: 359: 355: 353: 348: 346: 342: 338: 333: 331: 326: 321: 319: 309: 305: 303: 293: 291: 286: 282: 280: 276: 267: 265: 261: 257: 253: 249: 243: 241: 237: 233: 229: 219: 217: 213: 209: 205: 200: 198: 194: 190: 186: 182: 178: 170: 166: 158: 154: 150: 147: 145: 141: 138: 134: 130: 127: 123: 120: 116: 112: 108: 106: 105:Complications 102: 99: 95: 93: 89: 86: 85:Endocrinology 83: 81: 77: 73: 72:Robert Wadlow 69: 65: 60: 56: 52: 47: 41: 37: 33: 19: 1985:Human height 1958: 1947:Psychosocial 1858:. Retrieved 1851:the original 1822: 1798: 1787: 1772: 1753: 1734: 1694: 1686:Bibliography 1672: 1660:. Retrieved 1656:the original 1646: 1611: 1607: 1597: 1554: 1550: 1508: 1504: 1498: 1449: 1445: 1438: 1395: 1391: 1343: 1339: 1329: 1284: 1280: 1274: 1247: 1243: 1187: 1183: 1127: 1123: 1113: 1096: 1086: 1051: 1047: 1037: 1004: 1000: 993: 958: 954: 944: 899: 895: 892:"Acromegaly" 885: 860: 856: 796: 792: 761:. Retrieved 757: 748: 734: 722:. Retrieved 718: 709: 697:. Retrieved 693: 684: 675: 667: 554: 541: 537: 533: 526: 522: 518: 516: 501: 475: 424: 417: 409:somatostatin 405: 391: 383: 375: 360: 356: 349: 334: 323:Some common 322: 315: 306: 299: 287: 283: 273: 248:hypertension 244: 225: 204:growth plate 201: 188: 184: 176: 164: 163: 40: 1922:malfunction 1824:MedlinePlus 1652:"Gigantism" 1130:(1): 8–12. 1044:"Gigantism" 672:"Gigantism" 557:circulatory 433:Terminology 393:Pegvisomant 264:adolescence 157:pegvisomant 122:Hyperplasia 54:Other names 1974:Categories 1800:DiseasesDB 1287:(1): 1–9. 659:References 582:Acromegaly 552:regiment. 548:'s famous 427:acromegaly 352:sequencing 260:acromegaly 212:acromegaly 153:lanreotide 149:Octreotide 144:Medication 1959:Gigantism 1952:Ateliosis 1920:endocrine 1860:30 August 1698:. BRILL. 1630:0804-4643 1571:0021-972X 1474:0036-8075 1412:0163-769X 1204:1366-8714 1144:2287-1012 1070:0021-972X 1021:0021-972X 977:1479-6805 918:1750-1172 813:1479-6821 637:Megafauna 493:Anna Swan 491:Giantess 420:titration 413:radiation 380:Treatment 325:mutations 277:(GH) and 252:pediatric 165:Gigantism 132:Treatment 80:Specialty 49:Gigantism 1932:Dwarfism 1662:14 March 1638:16061823 1589:18492755 1525:26585365 1490:37013760 1482:16728643 1430:23371967 1370:25470569 1309:19528310 1301:15480774 1266:11133160 1222:11577173 1162:25883921 1105:25905205 1097:Endotext 1078:10599691 985:26136383 936:18578866 877:28483363 831:26187128 763:27 April 724:27 April 699:27 April 642:Nephilim 592:Dwarfism 575:See also 567:and the 531:genitive 508:genetics 472:wrestler 312:Genetics 290:upstream 242:(GHRH). 232:adenomas 189:giantism 185:gĂ­gantes 98:insomnia 92:Symptoms 57:Giantism 18:Giantism 1794:D005877 1580:2515082 1454:Bibcode 1446:Science 1421:3610678 1361:4291174 1213:1187088 1153:4397276 1029:8421089 927:2459162 822:6533620 602:Goliath 542:megalou 540:, gen. 534:somatos 453:Finnish 395:is one 318:genetic 216:somatic 193:average 124:in the 1866:  1829:001174 1745:5A60.0 1702:  1636:  1628:  1587:  1577:  1569:  1523:  1488:  1480:  1472:  1428:  1418:  1410:  1368:  1358:  1307:  1299:  1264:  1220:  1210:  1202:  1160:  1150:  1142:  1103:  1076:  1068:  1027:  1019:  983:  975:  934:  924:  916:  902:: 17. 875:  829:  819:  811:  529:body, 343:and a 118:Causes 1854:(PDF) 1847:(PDF) 1805:30730 1783:253.0 1768:E34.4 1764:E22.0 1486:S2CID 1305:S2CID 569:heart 565:bones 538:megas 519:hyper 455:giant 401:IGF-I 222:Cause 181:giant 177:gĂ­gas 173:γίγας 169:Greek 1862:2004 1789:MeSH 1778:9-CM 1749:5B12 1700:ISBN 1664:2012 1634:PMID 1626:ISSN 1585:PMID 1567:ISSN 1521:PMID 1478:PMID 1470:ISSN 1426:PMID 1408:ISSN 1366:PMID 1297:PMID 1262:PMID 1218:PMID 1200:ISSN 1158:PMID 1140:ISSN 1101:PMID 1074:PMID 1066:ISSN 1025:PMID 1017:ISSN 981:PMID 973:ISSN 932:PMID 914:ISSN 873:PMID 827:PMID 809:ISSN 765:2017 726:2017 701:2017 527:soma 523:soma 470:, a 425:See 1774:ICD 1755:ICD 1736:ICD 1616:doi 1612:153 1575:PMC 1559:doi 1513:doi 1462:doi 1450:312 1416:PMC 1400:doi 1356:PMC 1348:doi 1344:371 1289:doi 1285:209 1252:doi 1248:229 1208:PMC 1192:doi 1148:PMC 1132:doi 1056:doi 1009:doi 963:doi 959:226 922:PMC 904:doi 865:doi 817:PMC 801:doi 674:at 559:or 337:AIP 179:, " 155:or 34:or 1976:: 1827:: 1803:: 1792:: 1781:: 1766:, 1762:: 1759:10 1747:, 1743:: 1740:11 1632:. 1624:. 1610:. 1606:. 1583:. 1573:. 1565:. 1555:93 1553:. 1549:. 1533:^ 1519:. 1509:76 1507:. 1484:. 1476:. 1468:. 1460:. 1448:. 1424:. 1414:. 1406:. 1396:34 1394:. 1390:. 1378:^ 1364:. 1354:. 1342:. 1338:. 1317:^ 1303:. 1295:. 1283:. 1260:. 1246:. 1242:. 1230:^ 1216:. 1206:. 1198:. 1188:54 1186:. 1182:. 1170:^ 1156:. 1146:. 1138:. 1128:20 1126:. 1122:. 1072:. 1064:. 1052:84 1050:. 1046:. 1023:. 1015:. 1005:76 1003:. 979:. 971:. 957:. 953:. 930:. 920:. 912:. 898:. 894:. 871:. 861:78 859:. 839:^ 825:. 815:. 807:. 797:22 795:. 791:. 773:^ 756:. 717:. 692:. 571:. 415:. 369:, 365:, 175:, 171:: 151:, 1911:e 1904:t 1897:v 1864:. 1776:- 1757:- 1738:- 1728:D 1708:. 1666:. 1640:. 1618:: 1591:. 1561:: 1527:. 1515:: 1492:. 1464:: 1456:: 1432:. 1402:: 1372:. 1350:: 1311:. 1291:: 1268:. 1254:: 1224:. 1194:: 1164:. 1134:: 1107:. 1080:. 1058:: 1031:. 1011:: 987:. 965:: 938:. 906:: 900:3 879:. 867:: 833:. 803:: 767:. 728:. 703:. 167:( 38:. 20:)

Index

Giantism
Deep-sea gigantism
Island gigantism

Robert Wadlow
Specialty
Endocrinology
Symptoms
insomnia
Complications
delayed puberty
Hyperplasia
pituitary gland
pituitary gland
Medication
Octreotide
lanreotide
pegvisomant
Greek
giant
average
growth hormone
growth plate
pituitary gland
acromegaly
somatic
growth hormone
adenomas
anterior pituitary gland
growth hormone releasing hormone

Text is available under the Creative Commons Attribution-ShareAlike License. Additional terms may apply.

↑